Bacterial Culture, Cystic Fibrosis, Respiratory
Use
This test is useful for detecting disease-causing aerobic bacteria in specimens from patients with cystic fibrosis. Chronic lung infection is responsible for a major portion of deaths in cystic fibrosis patients. The test isolates bacteria commonly associated with pulmonary disease in CF patients, like Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia complex among others.
Special Instructions
If antimicrobial susceptibilities are needed, order CFRCS / Bacterial Culture, Cystic Fibrosis with Antimicrobial Susceptibilities, Varies. Specimen source is required. The specimen must arrive within 48 hours of collection.
Limitations
The test may not detect bacterial agents like mycobacteria, Legionella species, or Mycoplasma pneumoniae. Negative results do not exclude the possibility of infectious lung disease. Overgrowth of usual oropharyngeal microbiota can occur if culture of sputum is delayed. Clinicians should consider additional testing for bacterial, viral, or fungal agents if the culture is negative.
FDA ApprovedNew York Approved
Methodology
Culture-based
Biomarkers
LOINC Codes
- 44798-7
- 44798-7
Result Turnaround Time
5-12 days
Related Documents
For more information, please review the documents below
Specimen
Sputum
Volume
Entire collection
Minimum Volume
Not provided
Container
Sterile container
Collection Instructions
Have the patient brush their teeth or gargle with water immediately prior to specimen collection to reduce contaminating bacteria.
Patient Preparation
Brush teeth or gargle with water.
Causes for Rejection
Dry swab
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 48 hours |